1. LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: A mendelian randomization analysis. (August 2018) Authors: Ference, B.A.; Burgess, S.; Staley, J.R.; Freitag, D.F.; Mason, A.M.; Nielsen, S.F.; Willeit, P.; Young, R.; Surendran, P.; Karthikeyan, S.; Bolton, T.R.; Peters, J.E.; Kamstrup, P.R.; Tybjærg-Hansen, A.; Benn, M.; Langsted, A.; Schnohr, P.; Vedel-Krogh, S.; Kobylecki, C.J.; Ford, I. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗